Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine development
Pharma
Moderna plots launch of its next potential mRNA vaccine approval
Moderna expects initial approvals of its RSV vaccine to start rolling in during the first half of 2024, teeing up a potential U.S. launch this fall.
Fraiser Kansteiner
May 2, 2024 11:08am
GSK launches mRNA patent infringement case against Pfizer
Apr 26, 2024 10:04am
Judge pauses Moderna's infringement case against rival Pfizer
Apr 15, 2024 4:47pm
Pfizer plots new RSV filing with positive Abrysvo data in adults
Apr 9, 2024 6:45am
Moderna's CEO takes slight pay cut during 'transition year'
Mar 12, 2024 10:47am
After cuts, Novavax's Q4 performance startles investors
Feb 28, 2024 9:38am